Microarray Technology Overview and Applications
Uploaded by
Kristyn RiveraMicroarray Technology Overview and Applications
Uploaded by
Kristyn RiveraCommon questions
Powered by AIWhen designing probes for 25-35 mers, key considerations include probe length (default 30 bases), probe length tolerance (default 3), targeted melting temperature Tm (default 63°C), and Tm tolerance (+) (default 5). Other parameters such as hairpin maximum ΔG (default 4 Kcal/mol) and self-dimer ΔG (default 7 Kcal/mol) are critical for ensuring probe stability and specificity. It is also important that the probes avoid cross-homology by being BLAST searched against the appropriate genome category .
Microarray technology has revolutionized cancer research by enabling researchers to classify cancer types based on gene expression profiles rather than just the organs where tumors develop. This genomic approach to classification allows for a more precise understanding of cancer behaviors and the biological pathways involved. As a result, microarray technology assists in developing targeted treatments that are tailored to the specific genetic characteristics of a cancer type, improving the effectiveness of therapies and minimizing side effects .
Microarray technology contributes to gene discovery by facilitating the identification of new genes and determining their functional roles and expression levels under various conditions. This is achieved by analyzing gene expression patterns across multiple samples simultaneously, which allows researchers to observe which genes are active, how their expression is regulated, and how they interact with each other. Such insights are crucial for elucidating cellular processes and understanding the molecular basis of health and disease, potentially leading to the development of new diagnostic tools and therapeutics .
DNA Microarray technology aids drug discovery by allowing researchers to conduct comparative analysis of genes from diseased and normal cells. This helps identify the biochemical makeup of proteins synthesized by diseased genes, informing the synthesis of drugs that target and reduce the effects of these proteins. Pharmacogenomics further enhances drug discovery by studying the correlations between patients' genetic profiles and their therapeutic responses to drugs, leading to targeted and effective treatments .
In microarray probe design, the 'hairpin max ΔG' and 'self-dimer ΔG' parameters are crucial for ensuring probe specificity and stability. Hairpin structures can form if the probe sequence complements itself, leading to reduced hybridization efficiency with target DNA. A low hairpin max ΔG value indicates a lower propensity for hairpin formation. Similarly, the self-dimer ΔG measures the tendency of probes to dimerize with themselves rather than bind to target sequences. Optimal values minimize these secondary structures, ensuring that probes remain single-stranded and available for target binding .
In a typical microarray experiment, hybridization occurs when mRNA molecules from a sample bind to their complementary DNA probes on the microarray. The mRNA molecules are first labeled with fluorescent dyes, and as they bind to the DNA spots on the array, the level of fluorescence at each spot indicates the expression level of the corresponding gene. The intensity of the fluorescence provides quantifiable data that researchers use to determine which genes are active and to what extent, thus creating a gene expression profile for the sample .
Microarrays provide significant benefits in toxicological research by allowing for the analysis of changes in gene expression in response to toxicant exposure. This can help identify pathways affected by toxins, thereby informing risk assessment and regulatory decisions. Furthermore, toxicogenomics can explore genetic variations that affect individual susceptibility to toxins. However, challenges include the complexity of interpreting large datasets, the need for comprehensive reference databases, and potential variability in results due to differences in experimental conditions or biological samples .
The Gene Expression Omnibus (GEO) is a data repository created by the National Center for Biotechnology Information (NCBI) to facilitate the accessibility of gene expression data collected through microarray technology. GEO provides a centralized platform where researchers can access data related to gene expression, which were previously scattered and not readily accessible for public use. This has significantly improved the ability of the scientific community to share and utilize comprehensive gene expression data for further research and analysis .
Microarray technology is employed for bacterial identification by analyzing the expression of genes specific to different bacterial species. This method provides rapid and accurate identification of bacteria compared to traditional methods, which are often time-consuming and labor-intensive. Microarrays can test thousands of genes simultaneously, leading to quicker diagnosis, especially in clinical settings. This enhanced capability aids in tracking outbreaks and tailoring antibiotic therapies to effectively combat infections .
Microarray Expression Analysis focuses on comparing gene expression levels between samples from normal and diseased tissues by immobilizing cDNA derived from known mRNA. It identifies genes that are differentially expressed under certain conditions. Microarray for Mutation Analysis uses genomic DNA to detect Single Nucleotide Polymorphisms (SNPs), which are variations of a single nucleotide base between sequences. Comparative Genomic Hybridization is used to identify changes in chromosomal regions, such as increases or decreases in important chromosomal fragments that may contribute to disease .